Wei‐han Hu

发表

Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.

S. Liang, Y. Mao, Jun Ma, 2016, The Lancet. Oncology.

P16INK4A as a surrogate biomarker for human papillomavirus‐associated oropharyngeal carcinoma: Consideration of some aspects

R. Sun, Hui Lin, Hongzhi Wang, 2013, Cancer science.

Chinese Anti鄄 Cancer a Ssociation

Wei Zhang, Y. Zhou, R. Sun, 2011 .

HPV Infection and Anemia Status Stratify the Survival of Early T2 Laryngeal Squamous Cell Carcinoma.

R. Sun, Hui Lin, Hongzhi Wang, 2015, Journal of voice : official journal of the Voice Foundation.

Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.

Yingqin Li, Y. Mao, Jun Ma, 2019, The New England journal of medicine.

The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era.

H. Mo, D. Luo, Peijing Li, 2018, Oral oncology.

10-Year Results of Therapeutic Ratio by Intensity-Modulated Radiotherapy Versus Two-Dimensional Radiotherapy in Patients with Nasopharyngeal Carcinoma.

Li-Zhi Liu, Jun Ma, A. Lin, 2018, The oncologist.

Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma

Wen-Qi Jiang, Ying Jin, Ye Cao, 2012, Journal of Cancer Research and Clinical Oncology.

Expression TGM2 and BNIP3 have prognostic significance in laryngeal cancer patients receiving surgery and postoperative radiotherapy: A retrospective study

R. Sun, Huan-xin Lin, Wen-kuan Chen, 2012, Journal of Translational Medicine.

A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study

Bi-Jun Huang, R. Sun, P. Xie, 2018, Journal of Cancer.

Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Y. Mao, Jun Ma, Liangfang Shen, 2021, The Lancet.

Effect of Prolonged Radiotherapy Treatment Time on Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma

H. Mo, D. Luo, Peijing Li, 2015, PloS one.

[Comparison between PET-CT and MRI in diagnosing nodal metastasis of nasopharyngeal carcinoma].

Li Li, Li-Zhi Liu, Quanshi Wang, 2005, Ai zheng = Aizheng = Chinese journal of cancer.

Reduced-Volume Irradiation of Uninvolved Neck in Patients With Nasopharyngeal Cancer: Updated Results From an Open-Label, Noninferiority, Multicenter, Randomized Phase III Trial

Y. Mao, Lei Chen, F. Xie, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial.

Ying Sun, Y. Mao, Jun Ma, 2022, The Lancet. Oncology.

Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma

T. Kang, Yi Liang, Xiangsheng Xiao, 2010, Journal of Translational Medicine.

Loss of LKB1 Expression Decreases the Survival and Promotes Laryngeal Cancer Metastasis

Jun Dong, Wei Wang, P. Sun, 2017, Journal of Cancer.

Meta-analysis of the clinical characteristics and prognostic relevance of NOTCH1 and FBXW7 mutation in T-cell acute lymphoblastic leukemia

Chengcheng Guo, Xinxiang Fan, Xiao Zhang, 2017, Oncotarget.

ABO blood group is a predictor of survival in patients with laryngeal cancer

Xiaozhong Chen, Peijing Li, T. Jin, 2016, Chinese journal of cancer.

[Study on prevention and treatment of radiotherapy caused post-visual pathway injury in nasopharyngeal carcinoma patients by traditional Chinese medicine].

Shi-xian Long, Wei‐han Hu, Bo-ping Xu, 2003, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long‐term results of phase 3 randomized controlled trial

Ying Sun, S. Liang, Y. Mao, 2019, International journal of cancer.

Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial

Ying Sun, Yingqin Li, Y. Mao, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.